Advancing the Development of Orphan Advanced Therapy Products

Keyword(s) Regulatory Affairs, Pharmaceuticals

Tag(s) Regulatory, Regulatory Affairs

A cheerful woman wearing glasses and a yellow blouse works at a desk with a laptop and pen in hand.

Description

Join DIA's Advanced Therapies Community for this upcoming webinar. The US Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) will facilitate a discussion on the topic of FDA programs and relevant policies available to support and advance the development and evaluation of new treatments for rare diseases.

Join us on Tuesday, November 18th from 12:00pm-1:00pm for this live DIA Direct Webinar!

FEATURED TOPICS

Orphan Product Designation
Orphan Drug Exclusivity Program
Rare Pediatric Disease Priority Review Voucher Program (RPD PRV)

Related Items
Others who viewed this also viewed